Reports for LAMIVUDINE

Ingredient

LAMIVUDINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699
APO-LAMIVUDINE HBV 100MG TABLET Resolved 2021-05-07 2021-06-28 138957
AURO-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Resolved 2021-05-05 2021-12-01 138774
APO-LAMIVUDINE 300MG TABLET Resolved 2021-02-26 2021-06-28 134757
APO-LAMIVUDINE HBV 100MG TABLET Resolved 2019-12-05 2020-02-25 100278
AURO-ABACAVIR/LAMIVUDINE 600MG 300MG TABLET Resolved 2019-09-05 2020-04-15 93077
APO-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-08-21 2020-01-27 92016
TRIZIVIR 300MG 300MG 150MG TABLET Resolved 2019-08-02 2021-12-08 90619
MYLAN-ABACAVIR/LAMIVUDINE 600MG 300MG TABLET Resolved 2019-05-28 2019-06-19 85021
APO-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-04-22 2019-07-29 82102

Showing 1 to 10 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HEPTOVIR 5MG SOLUTION Discontinued 2022-05-13 2022-07-22 160503
HEPTOVIR 100MG TABLET Discontinued 2022-05-13 2022-08-10 160500
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260
TRIZIVIR 300MG 300MG 150MG TABLET Discontinued 2019-09-18 2019-09-18 94278
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557

Showing 1 to 7 of 7